{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:41:48Z","timestamp":1772818908348,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/pai.0b013e3182a318a9","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T09:06:30Z","timestamp":1383296790000},"page":"530-536","source":"Crossref","is-referenced-by-count":28,"title":["Immunohistochemical Expression of Vascular Endothelial Growth Factor A in Advanced Gallbladder Carcinoma"],"prefix":"10.1097","volume":"22","author":[{"given":"Pablo","family":"Letelier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Buchegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Riquelme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Roa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210126","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjsurg.2007.11.011","article-title":". Gallbladder cancer.","volume":"196","author":"Gourgiotis","year":"2008","journal-title":"Am J Surg"},{"key":"R2-8-20210126","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","article-title":". Epidemiology and molecular pathology of gallbladder cancer.","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"R3-8-20210126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":". Carcinoma of the gallbladder.","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol"},{"key":"R4-8-20210126","first-page":"1540","article-title":". Gallbladder cancer in a high risk area: morphological features and spread patterns.","volume":"46","author":"Roa","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"R5-8-20210126","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","article-title":"Epidemiology of gallbladder disease: cholelithiasis and cancer.","volume":"6","author":"Stinton","year":"2012","journal-title":"Gut Liver"},{"key":"R6-8-20210126","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s005340100021","article-title":"Present status of the diagnosis and treatment of gallbladder carcinoma.","volume":"8","author":"Donohue","year":"2001","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R7-8-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1247\/csf.26.25","article-title":"Structure and function of VEGFVEGF-receptor system involved in angiogenesis.","volume":"26","author":"Shibuya","year":"2001","journal-title":"Cell Struct Funct"},{"key":"R8-8-20210126","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine.","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"R9-8-20210126","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors.","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"R10-8-20210126","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1634\/stemcells.21-1-118","article-title":"The molecular perspective: VEGF and angiogenesis.","volume":"21","author":"Goodsell","year":"2003","journal-title":"Stem Cells"},{"key":"R11-8-20210126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.med.49.1.407","article-title":"Angiogenesis and tumor metastasis.","volume":"49","author":"Zetter","year":"1998","journal-title":"Annu Rev Med"},{"key":"R12-8-20210126","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1134\/S0006297908070031","article-title":"Mechanisms of angiogenesis.","volume":"73","author":"Karamysheva","year":"2008","journal-title":"Biochemistry (Mosc)"},{"key":"R13-8-20210126","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcancer.2003.09.016","article-title":". Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin.","volume":"14","author":"Mercurio","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"R14-8-20210126","first-page":"12","article-title":"Vascular endothelial growth factor as a target for anticancer therapy.","volume":"9suppl","author":"Ferrara","year":"2004","journal-title":"Oncologist"},{"key":"R15-8-20210126","first-page":"1065","article-title":". Expression of vascular endothelial growth factor in human gallbladder lesions.","volume":"5","author":"Yamamoto","year":"1998","journal-title":"Oncol Rep"},{"key":"R16-8-20210126","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1072-7515(01)01012-2","article-title":". Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer.","volume":"193","author":"Quan","year":"2001","journal-title":"J Am Coll Surg"},{"key":"R17-8-20210126","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.3748\/wjg.v10.i18.2750","article-title":". Relationship between urokinase-type plasminogen activator receptor and vascular endothelial growth factor expression and metastasis of gallbladder cancer.","volume":"10","author":"Yue","year":"2004","journal-title":"World J Gastroenterol"},{"key":"R18-8-20210126","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.3748\/wjg.v11.i24.3724","article-title":". Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma.","volume":"11","author":"Zhi","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R19-8-20210126","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3748\/wjg.v12.i3.415","article-title":". Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity.","volume":"12","author":"Tian","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R20-8-20210126","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejso.2010.10.007","article-title":". The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder.","volume":"37","author":"Sergeant","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"R21-8-20210126","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s13277-011-0221-2","article-title":". Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma.","volume":"32","author":"Sun","year":"2011","journal-title":"Tumour Biol"},{"key":"R22-8-20210126","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1248\/bpb.34.1785","article-title":"Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy.","volume":"34","author":"Takahashi","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"R23-8-20210126","first-page":"353","article-title":"Targeting angiogenesis in cancer therapy.","volume":"65","author":"Ichihara","year":"2011","journal-title":"Acta Med Okayama"},{"key":"R24-8-20210126","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R25-8-20210126","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1158\/1078-0432.CCR-07-1991","article-title":". Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.","volume":"14","author":"Alvarez","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R26-8-20210126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(94)90187-2","article-title":"The implications of angiogenesis for the biology and therapy of cancer metastasis.","volume":"79","author":"Fidler","year":"1994","journal-title":"Cell"},{"key":"R27-8-20210126","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200318181","article-title":"HIF hydroxylation and the mammalian oxygen-sensing pathway.","volume":"111","author":"Safran","year":"2003","journal-title":"J Clin Invest"},{"key":"R28-8-20210126","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/edrv-13-1-18","article-title":". Molecular and biological properties of the vascular endothelial growth factor family of proteins.","volume":"13","author":"Ferrara","year":"1992","journal-title":"Endocr Rev"},{"key":"R29-8-20210126","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ejso.2003.09.013","article-title":". Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas.","volume":"29","author":"Giatromanolaki","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"R30-8-20210126","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10147-009-0011-7","article-title":". Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma.","volume":"15","author":"Batmunkh","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"R31-8-20210126","first-page":"1013","article-title":". Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer.","volume":"12","author":"Okita","year":"1998","journal-title":"Int J Oncol"},{"key":"R32-8-20210126","first-page":"68","article-title":". The roles of VEGF and C-myc in occurrence, development and metastasis of gallbladder carcinoma.","volume":"20","author":"Liu","year":"2003","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"key":"R33-8-20210126","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10147-008-0778-y","article-title":". Role of tumor angiogenesis in gallbladder carcinoma: with special reference to thymidine phosphorylase.","volume":"13","author":"Harino","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"R34-8-20210126","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U","article-title":"Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates.","volume":"70","author":"Henson","year":"1992","journal-title":"Cancer"},{"key":"R35-8-20210126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jso.2930340105","article-title":". Gallbladder adenocarcinoma: the prognostic significance of histologic grade.","volume":"34","author":"Johnson","year":"1987","journal-title":"J Surg Oncol"},{"key":"R36-8-20210126","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0039-6060(96)80089-4","article-title":". Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage.","volume":"120","author":"Tsukada","year":"1996","journal-title":"Surgery"},{"key":"R37-8-20210126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jso.2930390407","article-title":"Primary carcinoma of the gallbladder: TNM staging and prognosis.","volume":"39","author":"White","year":"1988","journal-title":"J Surg Oncol"},{"key":"R38-8-20210126","first-page":"101","article-title":"Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.","volume":"94suppl","author":"Burroughs","year":"2002","journal-title":"J Natl Med Assoc"},{"key":"R39-8-20210126","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1200\/JCO.2010.28.4075","article-title":". Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.","volume":"28","author":"Lubner","year":"2010","journal-title":"J Clin Oncol"},{"key":"R40-8-20210126","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2174\/138945010791320818","article-title":"Molecular targeted therapy of biliary tract cancer--results of the first clinical studies.","volume":"11","author":"Wiedmann","year":"2010","journal-title":"Curr Drug Targets"}],"container-title":["Applied Immunohistochemistry &amp; Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0b013e3182a318a9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:38:25Z","timestamp":1620967105000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129039-201408000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0b013e3182a318a9","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}